Literature DB >> 21081945

The clinical utility of precision medicine: properly assessing the value of emerging diagnostic tests.

B Shen1, J Hwang.   

Abstract

Assessments of the clinical utility of biomarkers and genomic tests often ignore individual utility and fail to account for downstream changes to the care delivery model. Tests that identify outliers are often undervalued in favor of those that help direct treatment for the "average" patient. By reducing uncertainty, these tests also enable lower-cost providers and even patients to assume increased responsibility for care in more convenient and affordable settings.

Entities:  

Mesh：

Year:  2010        PMID： 21081945     DOI： 10.1038/clpt.2010.236

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


  5 in total

Review 1.  The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?

Authors:  Mafalda M Dias; Michael J Sorich; Andrew Rowland; Michael D Wiese; Ross A McKinnon
Journal:  Pharm Res       Date:  2017-02-24       Impact factor: 4.200

2.  Personalizing healthcare: from genetics through payment to improving care?

Authors:  A E Finlayson; B Godman; K Paterson; E Aston; A Haycox; L L Gustafsson; R Ali
Journal:  J R Soc Med       Date:  2013-02       Impact factor: 5.344

Review 3.  Infectious Disease Management through Point-of-Care Personalized Medicine Molecular Diagnostic Technologies.

Authors:  Luc Bissonnette; Michel G Bergeron
Journal:  J Pers Med       Date:  2012-05-02

Review 4.  A path to precision in the ICU.

Authors:  David M Maslove; Francois Lamontagne; John C Marshall; Daren K Heyland
Journal:  Crit Care       Date:  2017-04-03       Impact factor: 9.097

Review 5.  Personalizing health care: feasibility and future implications.

Authors:  Brian Godman; Alexander E Finlayson; Parneet K Cheema; Eva Zebedin-Brandl; Inaki Gutiérrez-Ibarluzea; Jan Jones; Rickard E Malmström; Elina Asola; Christoph Baumgärtel; Marion Bennie; Iain Bishop; Anna Bucsics; Stephen Campbell; Eduardo Diogene; Alessandra Ferrario; Jurij Fürst; Kristina Garuoliene; Miguel Gomes; Katharine Harris; Alan Haycox; Harald Herholz; Krystyna Hviding; Saira Jan; Marija Kalaba; Christina Kvalheim; Ott Laius; Sven-Ake Lööv; Kamila Malinowska; Andrew Martin; Laura McCullagh; Fredrik Nilsson; Ken Paterson; Ulrich Schwabe; Gisbert Selke; Catherine Sermet; Steven Simoens; Dominik Tomek; Vera Vlahovic-Palcevski; Luka Voncina; Magdalena Wladysiuk; Menno van Woerkom; Durhane Wong-Rieger; Corrine Zara; Raghib Ali; Lars L Gustafsson
Journal:  BMC Med       Date:  2013-08-13       Impact factor: 8.775
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.